H.B. No. 1802

	AN ACT
	relating to a study on the use of alternative therapies for treating
	post-traumatic stress disorder.
	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
	SECTION 1.  (a) In this Act, "commission" means the Health
	and Human Services Commission.
	(b)  The commission, in collaboration with Baylor College of
	Medicine and in partnership with a military veterans hospital or a
	medical center that provides medical care to veterans, shall
	conduct a study on the efficacy of using alternative therapies,
	including the use of 3,4-methylenedioxymethamphetamine (MDMA),
	psilocybin, and ketamine, in the treatment of veterans who suffer
	from post-traumatic stress disorder.
	(c)  In conducting the study described by Subsection (b) of
	this section, the commission in collaboration with the Baylor
	College of Medicine shall:
	(1)  perform a clinical trial on the therapeutic
	efficacy of using psilocybin in the treatment of
	treatment-resistant post-traumatic stress disorder in veterans;
	and
	(2)  review current literature regarding:
	(A)  the safety and efficacy of
	3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and
	ketamine in the treatment of post-traumatic stress disorder; and
	(B)  the access veterans have to
	3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and
	ketamine for treatment of post-traumatic stress disorder in the
	United States.
	(d)  The commission shall prepare and submit to the governor,
	the lieutenant governor, the speaker of the house of
	representatives, and each member of the legislature:
	(1)  quarterly reports on the progress of the study
	conducted under this section; and
	(2)  not later than December 1, 2024, a written report
	containing the results of the study conducted under this section
	and any recommendations for legislative or other action.
	(e)  The commission shall ensure any protected health
	information collected during a clinical trial conducted under
	Subsection (c) of this section and reported under Subsection (d) of
	this section does not personally identify an individual.
	(f)  This Act expires September 1, 2025.
	SECTION 2.  The Agency is required to implement this Act only
	if the legislature appropriates money specifically for that
	purpose. If the legislature does not appropriate money
	specifically for that purpose, the commission may, but is not
	required to, implement this Act using other appropriations
	available for the purpose.
	SECTION 3.  This Act takes effect immediately if it receives
	a vote of two-thirds of all the members elected to each house, as
	provided by Section 39, Article III, Texas Constitution. If this
	Act does not receive the vote necessary for immediate effect, this
	Act takes effect September 1, 2021.
	______________________________	______________________________
	President of the Senate	Speaker of the House
	I certify that H.B. No. 1802 was passed by the House on May 6,
	2021, by the following vote:  Yeas 134, Nays 12, 1 present, not
	voting; and that the House concurred in Senate amendments to H.B.
	No. 1802 on May 28, 2021, by the following vote:  Yeas 134, Nays 9,
	2 present, not voting.
	______________________________
	Chief Clerk of the House
	I certify that H.B. No. 1802 was passed by the Senate, with
	amendments, on May 22, 2021, by the following vote:  Yeas 25, Nays
	5.
	______________________________
	Secretary of the Senate
	APPROVED: __________________
	Date
	__________________
	Governor